Literature DB >> 11003614

Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.

T Masaki1, Y Shiratori, W Rengifo, K Igarashi, K Matsumoto, M Nishioka, Y Hatanaka, M Omata.   

Abstract

Amplification found in a number of cyclin genes, especially in cyclin D and E, is an important event process that takes place in cancers, including hepatocellular carcinoma (HCC). The activities of a wide range of cell cycle-related kinases remain obscure in HCC. The purpose of the present study is to determine the cyclins and kinase activities of HCC in Long-Evans Cinnamon (LEC) rats. Cyclin D1, E, A, H, Cdk1(cyclin-dependent kinase; Cdc2), Cdk4, and Cdk6 protein levels were determined by Western blot analysis at different pathologic stages of liver tissues exhibiting HCC. Enzymatic activities of cyclin D1, E, A, Cdk4, Cdk6, Cdc2, Cdk7, and Wee1 kinase were measured by in-gel kinase assay. Protein levels and kinase activities of cyclin D1, E, Cdk4, cyclin A, and Wee1 increased proportionally with the development of HCC, especially in the transition process from chronic hepatitis to HCC. Although Cdc2 kinase activity was found to increase slightly from normal liver to chronic hepatitis, its activity remained unchanged in the process from chronic hepatitis to HCC. Cdk6 and Cdk7 activities remained unchanged in the process from normal liver to HCC. These data suggest that the increase in Cdc2 kinase may play a role in the process from normal liver to chronic hepatitis, whereas the predominant increase in cyclin D1, Cdk4, cyclin E, cyclin A, and Wee1 suggests involvement not only in the process from normal liver to chronic hepatitis, but also during transition into HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003614     DOI: 10.1053/jhep.2000.17705

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Genome-wide screening of indicator genes for assessing the potential carcinogenic risk of Nanjing city drinking water.

Authors:  Rui Zhang; Shupei Cheng; Aimin Li; Jie Sun; Yan Zhang; Xuxiang Zhang
Journal:  Ecotoxicology       Date:  2011-03-22       Impact factor: 2.823

2.  Wilson disease and hepatocellular carcinoma.

Authors:  Ruliang Xu; Cristina H Hajdu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

3.  Signal transduction disturbance related to hepatocarcinogenesis in mouse by prolonged exposure to Nanjing drinking water.

Authors:  Rui Zhang; Jie Sun; Yan Zhang; Shupei Cheng; Xiaowei Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2013-04-17       Impact factor: 4.223

4.  Functional and topological properties in hepatocellular carcinoma transcriptome.

Authors:  Ignat Drozdov; Jan Bornschein; Thomas Wex; Najl V Valeyev; Sophia Tsoka; Peter Malfertheiner
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

5.  Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma.

Authors:  Ya-Hui Huang; Kwang-Huei Lin; Chen-Hsin Liao; Ming-Wei Lai; Yi-Hsin Tseng; Chau-Ting Yeh
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

6.  6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcinomas through p38 MAPK phosphorylation and CDC25B dephosphorylation.

Authors:  Yong-Chun Li; Bong-Hee Kim; Soon-Chang Cho; Mi-Ae Bang; Sunmin Kim; Dae-Hun Park
Journal:  Int J Oncol       Date:  2014-11-07       Impact factor: 5.650

7.  The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.

Authors:  Ning Li; Ling Li; Yongshun Chen
Journal:  Oxid Med Cell Longev       Date:  2018-05-27       Impact factor: 6.543

Review 8.  Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.

Authors:  Cornelia Braicu; Claudia Burz; Ioana Berindan-Neagoe; Ovidiu Balacescu; Florin Graur; Victor Cristea; Alexandru Irimie
Journal:  Gastroenterology Res       Date:  2009-07-20

9.  Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.

Authors:  Eri Samukawa; Shintaro Fujihara; Kyoko Oura; Hisakazu Iwama; Yoshimi Yamana; Tomoko Tadokoro; Taiga Chiyo; Kiyoyuki Kobayashi; Asahiro Morishita; Mai Nakahara; Hideki Kobara; Hirohito Mori; Keiichi Okano; Yasuyuki Suzuki; Takashi Himoto; Tsutomu Masaki
Journal:  Int J Oncol       Date:  2017-10-23       Impact factor: 5.650

10.  A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification.

Authors:  Jingyuan Zhang; Xinkui Liu; Wei Zhou; Guoliang Cheng; Jiarui Wu; Siyu Guo; Shanshan Jia; Yingying Liu; Bingbing Li; Xiaomeng Zhang; Miaomiao Wang
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.